G蛋白失活作为成瘾治疗机制
本研究筛选可产生norBNI样κ阿片受体(KOR)失活的其他阿片配体,发现纳呋拉啡(G蛋白偏向性KOR激动剂)和纳美芬(KOR部分激动剂)也能产生持久KOR失活。KOR失活具性别依赖性,纳呋拉啡仅在雌鼠动情期(低雌激素状态)或孕酮处理后引起过氧化物产生;每日微剂量纳呋拉啡或纳美芬可阻断KOR介导的镇痛、应激诱导厌恶、阿片依赖小鼠急性和迁延性戒断中的烦躁及催乳素分泌,但不调控利尿和抗瘙痒KOR。作者认为两者有长期人体安全使用史,可能可重新用于治疗强啡肽介导的应激障碍。
要点
- 纳呋拉啡和纳美芬可产生norBNI样持久KOR失活,剂量比μ阿片受体作用所需低10至100倍。
- KOR失活具性别依赖性,纳呋拉啡仅在雌鼠动情期或孕酮处理后引起过氧化物产生。
- 每日微剂量纳呋拉啡或纳美芬可阻断KOR介导的镇痛、应激厌恶、戒断烦躁和催乳素分泌。
核心结论
- 纳呋拉啡和纳美芬可产生持久KOR失活,作者认为两者可能可重新用于治疗强啡肽介导的应激障碍。
研究设计与样本
- 本研究筛选可能产生norBNI样KOR失活的其他阿片配体,并观察纳呋拉啡和纳美芬的KOR失活效应。
主要发现
- 纳呋拉啡和纳美芬在比μ阿片受体作用所需低10至100倍的剂量下即可观察到KOR失活。
- KOR失活具性别依赖性,纳呋拉啡仅在雌鼠动情期(低雌激素状态)或孕酮处理后引起过氧化物产生。
- 每日微剂量纳呋拉啡或纳美芬可阻断KOR介导的镇痛效应、应激诱导厌恶、阿片依赖小鼠急性和迁延性戒断中的KOR介导烦躁及KOR诱导的催乳素分泌。
- 介利尿和抗瘙痒效应的KOR不受JNK调控。
临床怎么用
- 作者认为纳呋拉啡和纳美芬有长期人体安全使用史,可能可重新用于治疗强啡肽介导的应激障碍。
局限性
- 纳呋拉啡和纳美芬均非完全选择性KOR配体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The endogenous dynorphin/kappa opioid receptor (KOR) system in the brain mediates the dysphoric effects of stress, and KOR antagonists may have therapeutic potential for the treatment of drug addiction, depression, and psychosis. One class of KOR antagonists, the long-acting norbinaltorphimine (norBNI)-like antagonists, have been suggested to act by causing KOR inactivation through a c-Jun-kinase mechanism rather than by competitive inhibition. METHODS: In this study, we screened for other opioid ligands that might produce norBNI-like KOR inactivation and found that nalfurafine (a G-biased KOR agonist) and nalmefene (a KOR partial agonist) also produced long-lasting KOR inactivation. RESULTS: Neither nalfurafine nor nalmefene is a completely selective KOR ligand, but KOR inactivation was observed at doses 10- to 100-fold lower than necessary for mu opioid receptor actions. KOR inactivation is sex dependent, and we show that nalfurafine causes peroxide production only during estrus (low-estrogen state) or after progesterone treatment of female mice. Because KOR inactivation recovers slowly, daily treatment with submaximal drug doses causes accumulating inhibition. Daily microdosing with nalfurafine or nalmefene blocked KORs responsible for antinociceptive effects, blocked KORs mediating stress-induced aversion, mitigated KOR-mediated dysphoria during acute and protracted withdrawal in opioid-dependent mice, and blocked KOR-induced prolactin secretion. In contrast, KORs mediating the diuretic and antipruritic effects were not regulated by JNK (c-Jun N-terminal kinase). CONCLUSIONS: Both nalfurafine and nalmefene have long histories of safety and use in humans and could potentially be repurposed for the treatment of dynorphin-mediated stress disorders.
引用
- Neiswanger C, Ruiz MV, Kimball K, et al. G Protein Inactivation as a Mechanism for Addiction Treatment. Biol Psychiatry. 2025. PMID: 40189004. doi:10.1016/j.biopsych.2025.03.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。